Solute carrier family 6 member 2 (SLC6A2)
The SLC6A2 gene, located on chromosome 16q12.2, encodes the norepinephrine transporter (NET) protein. NET is a sodium/chloride-dependent transporter critical for regulating noradrenaline (norepinephrine) homeostasis through reuptake at synaptic clefts, primarily within the central nervous system and postganglionic sympathetic nerve terminals. Approximately 90% of synaptic norepinephrine is normally reabsorbed via NET, terminating adrenergic signaling.
Mutations or single nucleotide polymorphisms (SNPs) in SLC6A2 reduce NET availability or function, disrupting norepinephrine clearance. This imbalance can lead to orthostatic intolerance, syncope, postural tachycardia, and has been implicated in neuropsychiatric disorders such as ADHD and mood dysregulation. Moreover, NET dysfunction may influence the efficacy of antidepressant medications targeting norepinephrine pathways.
- Aids in the evaluation of unexplained syncope, orthostatic hypotension, or postural tachycardia
- Supports diagnostic workup in ADHD and related mood disorders
- Predicts possible antidepressant treatment resistance due to altered norepinephrine transporter function
Positive Result
Detection of pathogenic or likely pathogenic mutations/polymorphisms in SLC6A2 may indicate altered norepinephrine reuptake and associated clinical manifestations.
Negative Result
No disease-associated mutations or polymorphisms detected in SLC6A2. Does not entirely exclude functional NET dysfunction caused by non-genetic factors.
Negative (No pathogenic mutations or polymorphisms identified)
Whole blood (EDTA), buccal swab, saliva.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- J Affect Disord. 2014 Apr;158:127-32. [PMID: 24655776]
- Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19164-9. [PMID: 17146058]
- J Neurosci. 2003 Jun 1;23(11):4470-8. [PMID: 12805287]
- Sci Rep. 2021 Jun 10;11(1):12290. [PMID: 34112854]
- Psychiatr Genet. 2013 Oct;23(5):217-21. [PMID: 23969988]